Company Analysis Amedisys, Inc.
1. Summary
Advantages
- The stock's return over the last year (-2.2%) is higher than the sector average (-12.5%).
Disadvantages
- Price (91.9 $) is higher than fair price (2.07 $)
- Dividends (0%) are below the sector average (0.541%).
- Current debt level 20.6% has increased over 5 years from 0.6515%.
- The company's current efficiency (ROE=-0.9139%) is lower than the sector average (ROE=9.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Amedisys, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1% | 2.5% | 0% |
| 90 days | -4.5% | -17.8% | 2.4% |
| 1 year | -2.2% | -12.5% | 22.4% |
AMED vs Sector: Amedisys, Inc. has outperformed the "Healthcare" sector by 10.3% over the past year.
AMED vs Market: Amedisys, Inc. has significantly underperformed the market by -24.62% over the past year.
Stable price: AMED is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AMED with weekly volatility of -0.0424% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (91.9 $) is higher than the fair price (2.07 $).
Price is higher than fair: The current price (91.9 $) is 97.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (22.51) is lower than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (22.51) is lower than that of the market as a whole (49.04).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.78) is lower than that of the sector as a whole (4.83).
P/BV vs Market: The company's P/BV (2.78) is lower than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.39) is lower than that of the sector as a whole (33.77).
P/S vs Market: The company's P/S indicator (1.39) is lower than that of the market as a whole (10.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (15.92) is higher than that of the sector as a whole (-22.17).
EV/Ebitda vs Market: The company's EV/Ebitda (15.92) is lower than that of the market as a whole (28.32).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -21.06% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-21.06%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).
5.4. ROE
ROE vs Sector: The company's ROE (-0.9139%) is lower than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (-0.9139%) is lower than that of the market as a whole (10.71%).
5.5. ROA
ROA vs Sector: The company's ROA (-0.4731%) is lower than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (-0.4731%) is lower than that of the market as a whole (6.47%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (15.1%) is higher than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (15.1%) is higher than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.541%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (1.32%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
